<?xml version="1.0" encoding="UTF-8"?>
<p id="Par18">Several NMDs recognise immune-mediated pathogenesis. The extent to which immunosuppressive drugs can contribute to severe forms of SARS-CoV-2 infection is still unclear. Depending on the regional pandemic burden, patient compliance, and caregiversâ€™ support, NMD specialists may want to consider a reduction of the dose of some immunosuppressive drugs or shift to less immunosuppressive alternatives for high-risk patients [
 <xref ref-type="bibr" rid="CR6">6</xref>]. This decision should imply a careful discussion with the patients on the overall risk, specific benefits, and potential adverse events of the new treatment. Regarding corticosteroid therapy, abrupt withdrawal may induce flair of the underlying condition, requiring higher doses of steroids and increasing the risk for hospitalization [
 <xref ref-type="bibr" rid="CR39">39</xref>].
</p>
